CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 145 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.85 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,977,768 | -6.1% | 340,271 | +8.0% | 0.00% | 0.0% |
| Q2 2023 | $4,234,420 | +18747.3% | 315,061 | -76.7% | 0.00% | -84.6% |
| Q1 2023 | $22,467 | -47.8% | 1,355,095 | -41.4% | 0.01% | -45.8% |
| Q4 2022 | $43,034 | -99.8% | 2,313,666 | +60.6% | 0.02% | +118.2% |
| Q3 2022 | $18,480,000 | -3.2% | 1,440,358 | -47.1% | 0.01% | -8.3% |
| Q2 2022 | $19,095,000 | +97.9% | 2,723,895 | +134.1% | 0.01% | +140.0% |
| Q1 2022 | $9,648,000 | +515.7% | 1,163,809 | +402.9% | 0.01% | +400.0% |
| Q4 2021 | $1,567,000 | +446.0% | 231,432 | +327.1% | 0.00% | – |
| Q3 2021 | $287,000 | -83.3% | 54,186 | -81.9% | 0.00% | -100.0% |
| Q2 2021 | $1,721,000 | -39.0% | 299,373 | -51.1% | 0.00% | -50.0% |
| Q1 2021 | $2,821,000 | +93.2% | 612,010 | +40.0% | 0.00% | +100.0% |
| Q4 2020 | $1,460,000 | +1522.2% | 437,086 | +1344.0% | 0.00% | – |
| Q3 2020 | $90,000 | -92.7% | 30,269 | -88.6% | 0.00% | -100.0% |
| Q2 2020 | $1,225,000 | -61.8% | 265,053 | -68.2% | 0.00% | -71.4% |
| Q1 2020 | $3,207,000 | +2595.0% | 833,001 | +2528.2% | 0.01% | – |
| Q4 2019 | $119,000 | -70.4% | 31,695 | -58.2% | 0.00% | -100.0% |
| Q3 2019 | $402,000 | -20.7% | 75,846 | -43.4% | 0.00% | 0.0% |
| Q3 2018 | $507,000 | -89.9% | 134,019 | -91.7% | 0.00% | -85.7% |
| Q2 2018 | $5,024,000 | +52.1% | 1,610,176 | +16.5% | 0.01% | +75.0% |
| Q1 2018 | $3,304,000 | -59.1% | 1,382,258 | -33.1% | 0.00% | -63.6% |
| Q4 2017 | $8,082,000 | +12935.5% | 2,066,880 | +9060.1% | 0.01% | – |
| Q2 2017 | $62,000 | -47.0% | 22,564 | -62.4% | 0.00% | – |
| Q1 2017 | $117,000 | -65.2% | 60,067 | -81.2% | 0.00% | -100.0% |
| Q4 2016 | $336,000 | -35.5% | 319,868 | -33.1% | 0.00% | 0.0% |
| Q3 2016 | $521,000 | +13.3% | 478,164 | -26.2% | 0.00% | 0.0% |
| Q2 2016 | $460,000 | +1022.0% | 647,745 | +1748.2% | 0.00% | – |
| Q1 2016 | $41,000 | -93.2% | 35,048 | -85.9% | 0.00% | -100.0% |
| Q4 2015 | $607,000 | +1380.5% | 247,829 | +1708.7% | 0.00% | – |
| Q3 2015 | $41,000 | -43.8% | 13,702 | -22.6% | 0.00% | – |
| Q2 2015 | $73,000 | -79.6% | 17,700 | -78.5% | 0.00% | -100.0% |
| Q1 2015 | $357,000 | -73.0% | 82,372 | -79.3% | 0.00% | -75.0% |
| Q3 2014 | $1,321,000 | – | 397,870 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 589,883 | $590,000 | 1.38% |
| Broadfin Capital, LLC | 8,200,000 | $8,610,000 | 0.96% |
| Avoro Capital Advisors LLC | 1,141,149 | $1,198,000 | 0.24% |
| CORRADO ADVISORS, LLC | 190,600 | $200,000 | 0.12% |
| Baker Brothers Advisors | 5,102,153 | $5,357,000 | 0.05% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 756,311 | $794,000 | 0.04% |
| Point72 Asset Management, L.P. | 2,272,816 | $2,386,000 | 0.02% |
| AGRAN LIBBIE | 44,000 | $46,000 | 0.01% |
| COMPTON CAPITAL MANAGEMENT INC /RI | 10,000 | $11,000 | 0.01% |
| KENNEDY CAPITAL MANAGEMENT LLC | 233,171 | $245,000 | 0.00% |